Exercise and coping programs helped fatigue in MS review
By MS Buddy ·
Summarized from Neurodegenerative disease management, Nov 2026 · PubMed · DOI. AI-generated summary. Not medical advice.
Review · adults with MS and other diseases that progressively damage nerves
Research by Sarah Alageel, Katherine Deane and 1 colleague at the University of East Anglia in the United Kingdom.
Which approaches without drugs help manage fatigue in MS?
Key Takeaway
Exercise, therapy focused on thoughts and behavior, and self-management programs showed the most consistent benefits for MS fatigue in this review.

What They Found
Most evidence came from studies of MS. Structured exercise showed consistent benefits for fatigue compared with other study groups. Cognitive behavioral therapy (therapy focused on thoughts and behavior) and education or self-management programs also showed consistent benefits in MS. Findings were mixed for acupuncture (treatment using thin needles), light therapy, dietary changes, and electrical stimulation (treatment using electrical currents). Only two small trials involved Parkinson's disease, and no fatigue-focused treatment trials were found for the other conditions studied.
Who Should Care and Why
The review covered adults with MS, Parkinson's disease, and other diseases that progressively damage the nervous system. It focused on ways to manage fatigue without drugs. Studies involving people with dementia were excluded. The findings are most relevant to MS because it accounted for most of the evidence. Whether approaches studied in MS can help people with other conditions remains uncertain.
Important Considerations
This review mapped evidence from 27 sources, including research reviews and individual treatment studies; the abstract gives no total participant count. Differences in programs, study length, and fatigue measurements limited direct comparisons. These findings do not tell you which program would work best for a particular person.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in Neurodegenerative disease management by . Reproduced from the PubMed record.
Fatigue is a common and disabling symptom across several neurodegenerative diseases, including multiple sclerosis and Parkinson's disease. Non-pharmacological strategies are widely used in clinical practice to address fatigue, yet the extent to which evidence from one neurodegenerative condition can inform fatigue management in others remains uncertain, particularly for Parkinson's disease where intervention trials are scarce. To map the quantitative evidence on non-pharmacological interventions for fatigue in adults with neurodegenerative diseases (excluding dementias), and to identify potentially transferable strategies, gaps, and priorities for research and practice, with particular relevance to Parkinson's disease. Scoping review conducted according to Joanna Briggs Institute guidance and reported using the PRISMA Extension for Scoping Reviews (PRISMA-ScR). The protocol was preregistered on the Open Science Framework (OSF; DOI: 10.17605/OSF.IO/MJEYP). MEDLINE, Cochrane Library, CINAHL, AMED, and PsycINFO were searched for records published from January 2006 to 15 February 2025. Reference lists of relevant reviews and included studies were screened. Publications in English or Arabic were eligible. Quantitative interventional studies, mixed-methods studies with extractable quantitative fatigue outcomes, and systematic reviews/meta-analyses evaluating non-pharmacological interventions for fatigue in adults with progressive neurodegenerative conditions were eligible. Conditions of interest included multiple sclerosis, Parkinson's disease, motor neurone disease, Huntington's disease, hereditary ataxias, multiple system atrophy, and progressive supranuclear palsy. Studies focusing solely on pharmacological, surgical, herbal, or homeopathic interventions, qualitative-only studies, and studies in dementias were excluded. A bespoke charting form captured study design, population, intervention, comparator, delivery format, fatigue measures, and key findings. Studies were grouped by intervention type: exercise, psychological, educational, and complementary interventions. Systematic reviews/meta-analyses and primary intervention studies were synthesized as distinct evidence levels and were not combined quantitatively. The search identified 12,618 records. After removal of 5,399 duplicates, 7,219 records were screened and 517 full-text articles were assessed for eligibility. Twenty-seven sources met the inclusion criteria: seven systematic reviews/meta-analyses, 16 randomized controlled trials, one non-randomized controlled study, and three uncontrolled pre-post studies. Evidence was dominated by multiple sclerosis, with only two small trials in Parkinson's disease and no fatigue-focused intervention trials in other progressive neurodegenerative conditions. The most consistent between-group benefits were observed for structured exercise, cognitive behavioral therapy, and educational/self-management programs in multiple sclerosis. Complementary interventions included acupuncture, light therapy, dietary interventions, and electrical stimulation; evidence across these approaches was mixed. Heterogeneity in intervention type, intensity, duration, supervision and delivery format, follow-up duration, and fatigue outcome measures limited direct comparison across studies. Non-pharmacological interventions for fatigue in neurodegenerative disease are most developed in multiple sclerosis, where structured exercise, cognitive behavioral therapy, and educational/self-management approaches show the most consistent benefit. Evidence for Parkinson's disease is sparse, and no fatigue-focused intervention trials were identified in other progressive neurodegenerative conditions. Future work should prioritize condition-specific feasibility and effectiveness studies, harmonized fatigue outcome sets, objective fatigability measures alongside patient-reported fatigue, and multimodal programs with clearly specified therapeutic targets.
Categories
Explore more research
Related MS research

11/17/2026
A review suggests MS fatigue may reflect extra effort to control movement and incomplete recovery af
Read More
11/16/2026
Computer studies found MS fatigue surveys can give similar group results but different individual sc
Read More
11/17/2026
Donated MS brain tissue showed damage in a vision hub. Mouse findings linked local immune cell activ
Read More
1/1/2026
A study of 318 people with MS linked lower thinking test scores to more sexual difficulties, with th
Read More
11/14/2026
In a review of records for 173 people taking Mavenclad for MS, most had no relapses over two years.
Read More
11/14/2026
In a study of people with MS, those with greater disability reported more voice problems and vocal f
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
